S:D614G and S:H655Y are gateway mutations that act epistatically to promote SARS-CoV-2 variant fitness
暂无分享,去创建一个
James B. Munro | J. Luban | Xuping Xie | P. Shi | K. Shen | Javier A. Jaimes | M. A. Díaz-Salinas | Leonid A Yurkovetskiy | Chaitanya Kurhade | M. Choudhary | Thomas Nyalile | A. Dauphin | S. Egri | Jonathan Z. Li | Ann Dauphin | T. Nyalile
[1] A. Finzi,et al. Divergent SARS-CoV-2 variant emerges in white-tailed deer with deer-to-human transmission , 2022, Nature Microbiology.
[2] C. Davis,et al. Cross-neutralization and viral fitness of SARS-CoV-2 Omicron sublineages , 2022, bioRxiv.
[3] T. de Oliveira,et al. Persistent SARS-CoV-2 infection with accumulation of mutations in a patient with poorly controlled HIV infection , 2022, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[4] Shuntai Zhou,et al. Accelerated SARS-CoV-2 intrahost evolution leading to distinct genotypes during chronic infection , 2023, Cell Reports Medicine.
[5] Pardis C Sabeti,et al. Analysis of 6.4 million SARS-CoV-2 genomes identifies mutations associated with fitness , 2022, Science.
[6] N. Loman,et al. The origins and molecular evolution of SARS-CoV-2 lineage B.1.1.7 in the UK , 2022, bioRxiv.
[7] G. Ye,et al. Cryo-EM structure of a SARS-CoV-2 omicron spike protein ectodomain , 2022, Nature Communications.
[8] L. Poon,et al. Transmission of SARS-CoV-2 delta variant (AY.127) from pet hamsters to humans, leading to onward human-to-human transmission: a case study , 2022, The Lancet.
[9] H. Mo,et al. Remdesivir and GS-441524 Retain Antiviral Activity against Delta, Omicron, and Other Emergent SARS-CoV-2 Variants , 2022, bioRxiv.
[10] Liyuan Liu,et al. Cryo-EM structure of the SARS-CoV-2 Omicron spike , 2022, Cell Reports.
[11] N. Krogan,et al. Mutations in SARS-CoV-2 variants of concern link to increased spike cleavage and virus transmission , 2022, Cell Host & Microbe.
[12] T. Ndung’u,et al. SARS-CoV-2 prolonged infection during advanced HIV disease evolves extensive immune escape , 2022, Cell Host & Microbe.
[13] A. Darby,et al. Rapid selection of P323L in the SARS-CoV-2 polymerase (NSP12) in humans and non-human primate models and confers a large plaque phenotype , 2021, bioRxiv.
[14] M. Nelson,et al. SARS-CoV-2 infection in free-ranging white-tailed deer , 2021, Nature.
[15] E. Ghedin,et al. Yearlong COVID-19 Infection Reveals Within-Host Evolution of SARS-CoV-2 in a Patient With B-Cell Depletion , 2021, The Journal of infectious diseases.
[16] M. Kraemer,et al. Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa , 2021, Nature.
[17] Graham W. Taylor,et al. SARS-CoV-2 lineage dynamics in England from September to November 2021: high diversity of Delta sub-lineages and increased transmissibility of AY.4.2 , 2021, BMC Infectious Diseases.
[18] G. Wallau,et al. Identification of a novel SARS-CoV-2 P.1 sub-lineage in Brazil provides new insights about the mechanisms of emergence of variants of concern , 2021, Virus evolution.
[19] Philip L. Tzou,et al. Coronavirus Resistance Database (CoV-RDB): SARS-CoV-2 susceptibility to monoclonal antibodies, convalescent plasma, and plasma from vaccinated persons , 2021, bioRxiv.
[20] Vineet D. Menachery,et al. The N501Y spike substitution enhances SARS-CoV-2 infection and transmission , 2021, Nature.
[21] N. French,et al. SARS-CoV-2 exposure in Malawian blood donors: an analysis of seroprevalence and variant dynamics between January 2020 and July 2021 , 2021, BMC Medicine.
[22] M. C. Muenker,et al. De novo emergence of a remdesivir resistance mutation during treatment of persistent SARS-CoV-2 infection in an immunocompromised patient: a case report , 2021, Nature Communications.
[23] James B. Munro,et al. Conformational dynamics and allosteric modulation of the SARS-CoV-2 spike , 2021, bioRxiv.
[24] G. Kochs,et al. Antibody escape and global spread of SARS-CoV-2 lineage A.27 , 2021, Nature communications.
[25] Graham W. Taylor,et al. Exponential growth, high prevalence of SARS-CoV-2, and vaccine effectiveness associated with the Delta variant , 2021, Science.
[26] E. Ghedin,et al. Yearlong COVID-19 Infection Reveals Within-Host Evolution of SARS-CoV-2 in a Patient With B-Cell Depletion , 2021, medRxiv.
[27] S. Scheres,et al. New tools for automated cryo-EM single-particle analysis in RELION-4.0 , 2021, bioRxiv.
[28] M. Nussenzweig,et al. High genetic barrier to SARS-CoV-2 polyclonal neutralizing antibody escape , 2021, Nature.
[29] Pardis C Sabeti,et al. Analysis of 6.4 million SARS-CoV-2 genomes identifies mutations associated with fitness , 2021, medRxiv.
[30] James B. Munro,et al. Stability and conformation of the dimeric HIV-1 genomic RNA 5′UTR , 2021, Biophysical journal.
[31] Nuno R. Faria,et al. Global disparities in SARS-CoV-2 genomic surveillance , 2021, medRxiv.
[32] O. Tsang,et al. The impact of spike N501Y mutation on neutralizing activity and RBD binding of SARS-CoV-2 convalescent serum , 2021, EBioMedicine.
[33] D. Wesemann,et al. Membrane fusion and immune evasion by the spike protein of SARS-CoV-2 Delta variant , 2021, bioRxiv.
[34] Vineet D. Menachery,et al. Delta spike P681R mutation enhances SARS-CoV-2 fitness over Alpha variant , 2021, bioRxiv.
[35] D. O’Connor,et al. Acute SARS-CoV-2 infections harbor limited within-host diversity and transmit via tight transmission bottlenecks , 2021, PLoS pathogens.
[36] N. Loman,et al. Generation and transmission of interlineage recombinants in the SARS-CoV-2 pandemic , 2021, Cell.
[37] Nuno R. Faria,et al. Neutralisation of SARS-CoV-2 lineage P.1 by antibodies elicited through natural SARS-CoV-2 infection or vaccination with an inactivated SARS-CoV-2 vaccine: an immunological study , 2021, The Lancet Microbe.
[38] J. Dushoff,et al. The origins and potential future of SARS-CoV-2 variants of concern in the evolving COVID-19 pandemic , 2021, Current Biology.
[39] P. Kaleebu,et al. Emergence and spread of a SARS-CoV-2 lineage A variant (A.23.1) with altered spike protein in Uganda , 2021, Nature Microbiology.
[40] Manoj Kumar Singh,et al. Genomic characterization and epidemiology of an emerging SARS-CoV-2 variant in Delhi, India , 2021, Science.
[41] William T. Harvey,et al. SARS-CoV-2 variants, spike mutations and immune escape , 2021, Nature Reviews Microbiology.
[42] S. Whelan,et al. SARS-CoV-2 Spreads through Cell-to-Cell Transmission , 2021, bioRxiv.
[43] G. Barton,et al. Effects of common mutations in the SARS-CoV-2 Spike RBD domain and its ligand the human ACE2 receptor on binding affinity and kinetics , 2021, bioRxiv.
[44] G. Kochs,et al. Within-host evolution of SARS-CoV-2 in an immunosuppressed COVID-19 patient as a source of immune escape variants , 2021, Nature Communications.
[45] M. Giacca,et al. The furin cleavage site in the SARS-CoV-2 spike protein is required for transmission in ferrets , 2021, Nature Microbiology.
[46] M. Suchard,et al. Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil , 2021, Science.
[47] Rommie E. Amaro,et al. Structure and dynamics of SARS-CoV-2 proofreading exoribonuclease ExoN , 2021, bioRxiv.
[48] T. Ndung’u,et al. Escape of SARS-CoV-2 501Y.V2 from neutralization by convalescent plasma , 2021, Nature.
[49] Graham W. Taylor,et al. Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England , 2021, Nature.
[50] J. Todd,et al. SARS-CoV-2 within-host diversity and transmission , 2021, Science.
[51] A. Godzik,et al. Detection of a SARS-CoV-2 variant of concern in South Africa , 2021, Nature.
[52] D. Fremont,et al. Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies , 2021, Nature Medicine.
[53] W. Hanage,et al. SARS-CoV-2 Sequence Characteristics of COVID-19 Persistence and Reinfection , 2021, medRxiv.
[54] M. Beer,et al. SARS-CoV-2 spike D614G change enhances replication and transmission , 2021, Nature.
[55] Nikolaos S. Alachiotis,et al. Population Genomics Insights into the First Wave of COVID-19 , 2021, Life.
[56] Graham W. Taylor,et al. SARS-CoV-2 evolution during treatment of chronic infection , 2021, Nature.
[57] D. Ho,et al. Antibody Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7 , 2021, bioRxiv.
[58] Vineet D. Menachery,et al. Loss of furin cleavage site attenuates SARS-CoV-2 pathogenesis , 2021, Nature.
[59] M. Nussenzweig,et al. mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants , 2021, bioRxiv.
[60] L. Morris,et al. SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma , 2021, bioRxiv.
[61] Haiyong Peng,et al. SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity , 2020, Nature Communications.
[62] T. Halasa,et al. SARS-CoV-2 Transmission between Mink (Neovison vison) and Humans, Denmark , 2020, Emerging infectious diseases.
[63] Lisa E. Gralinski,et al. SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivo , 2020, Science.
[64] Gaurav D. Gaiha,et al. Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host , 2020, The New England journal of medicine.
[65] M. Koopmans,et al. Transmission of SARS-CoV-2 on mink farms between humans and mink and back to humans , 2020, Science.
[66] E. Fischer,et al. Case Study: Prolonged Infectious SARS-CoV-2 Shedding from an Asymptomatic Immunocompromised Individual with Cancer , 2020, Cell.
[67] Vineet D. Menachery,et al. Spike mutation D614G alters SARS-CoV-2 fitness , 2020, Nature.
[68] E. Koonin,et al. Ongoing Global and Regional Adaptive Evolution of SARS-CoV-2 , 2020, bioRxiv.
[69] Yongfei Cai,et al. Structural impact on SARS-CoV-2 spike protein by D614G substitution , 2020, bioRxiv.
[70] D. A. Jackson,et al. Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and Pathogenicity , 2020, Cell.
[71] Edward C. Holmes,et al. A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology , 2020, Nature Microbiology.
[72] Pardis C Sabeti,et al. Structural and Functional Analysis of the D614G SARS-CoV-2 Spike Protein Variant , 2020, bioRxiv.
[73] S. Rowland-Jones,et al. Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus , 2020, Cell.
[74] F. Balloux,et al. No evidence for increased transmissibility from recurrent mutations in SARS-CoV-2 , 2020, Nature Communications.
[75] M. Hoffmann,et al. A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells , 2020, Molecular Cell.
[76] Shinji Makino,et al. An Infectious cDNA Clone of SARS-CoV-2 , 2020, Cell Host & Microbe.
[77] K. Shi,et al. Structural basis of receptor recognition by SARS-CoV-2 , 2020, Nature.
[78] A. Walls,et al. Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein , 2020, Cell.
[79] Qiang Zhou,et al. Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2 , 2020, Science.
[80] B. Graham,et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation , 2020, Science.
[81] P. Niu,et al. Genome Composition and Divergence of the Novel Coronavirus (2019-nCoV) Originating in China , 2020, Cell Host & Microbe.
[82] E. Holmes,et al. A new coronavirus associated with human respiratory disease in China , 2020, Nature.
[83] Kai Zhao,et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin , 2020, Nature.
[84] E. Holmes,et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding , 2020, The Lancet.
[85] Y. Hu,et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China , 2020, The Lancet.
[86] G. Gao,et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019 , 2020, The New England journal of medicine.
[87] D. Veesler,et al. Structural insights into coronavirus entry , 2019, Advances in Virus Research.
[88] Timothy B Sackton,et al. Convergent evolution in the genomics era: new insights and directions , 2019, Philosophical Transactions of the Royal Society B.
[89] James B. Munro,et al. Direct Visualization of the Conformational Dynamics of Single Influenza Hemagglutinin Trimers , 2018, Cell.
[90] A. Gorbalenya,et al. A planarian nidovirus expands the limits of RNA genome size , 2018, bioRxiv.
[91] Simon R. Harris,et al. SNP-sites: rapid efficient extraction of SNPs from multi-FASTA alignments , 2016, bioRxiv.
[92] Daniel S. Terry,et al. Single-molecule imaging of non-equilibrium molecular ensembles on the millisecond timescale , 2016, Nature Methods.
[93] Henry Pinkard,et al. Advanced methods of microscope control using μManager software. , 2014, Journal of biological methods.
[94] Marc A Suchard,et al. Stability-mediated epistasis constrains the evolution of an influenza protein , 2013, eLife.
[95] K. Katoh,et al. MAFFT Multiple Sequence Alignment Software Version 7: Improvements in Performance and Usability , 2013, Molecular biology and evolution.
[96] T. Nabeshima,et al. Discovery of the First Insect Nidovirus, a Missing Evolutionary Link in the Emergence of the Largest RNA Virus Genomes , 2011, PLoS pathogens.
[97] Gonçalo R. Abecasis,et al. The Sequence Alignment/Map format and SAMtools , 2009, Bioinform..
[98] Xiaotao Lu,et al. High Fidelity of Murine Hepatitis Virus Replication Is Decreased in nsp14 Exoribonuclease Mutants , 2007, Journal of Virology.
[99] John D. Hunter,et al. Matplotlib: A 2D Graphics Environment , 2007, Computing in Science & Engineering.
[100] D. J. Kiviet,et al. Empirical fitness landscapes reveal accessible evolutionary paths , 2007, Nature.
[101] J. J. Bull,et al. Theory of Lethal Mutagenesis for Viruses , 2007, Journal of Virology.
[102] Alexander E Gorbalenya,et al. Discovery of an RNA virus 3'->5' exoribonuclease that is critically involved in coronavirus RNA synthesis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[103] John L. Sullivan,et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus , 2003, Nature.
[104] Manfred Eigen,et al. Error catastrophe and antiviral strategy , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[105] F Sachs,et al. A direct optimization approach to hidden Markov modeling for single channel kinetics. , 2000, Biophysical journal.
[106] J. Qin,et al. Miscellanea. Combining parametric and empirical likelihoods , 2000 .
[107] D. Myszka,et al. Improving biosensor analysis , 1999, Journal of molecular recognition : JMR.
[108] P Green,et al. Base-calling of automated sequencer traces using phred. II. Error probabilities. , 1998, Genome research.
[109] P. Green,et al. Base-calling of automated sequencer traces using phred. I. Accuracy assessment. , 1998, Genome research.
[110] COVID-19 Genomics UK (COG-UK) Consortium Report Number 6 , 2020 .